Euronext NV (OTCMKTS:ERNXY – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 15th, there was short interest totaling 1,172 shares, a decline of 47.8% from the September 30th total of 2,247 shares. Based on an average daily volume of 11,003 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s stock are sold short.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded shares of Euronext from a “hold” rating to a “strong-buy” rating in a report on Friday, October 2nd. One research analyst has rated the stock with a Strong Buy rating. According to data from MarketBeat, the stock currently has an average rating of “Strong Buy”.
Check Out Our Latest Analysis on Euronext
Euronext Trading Down 0.7%
OTCMKTS:ERNXY traded down $0.29 during trading hours on Friday, reaching $39.16. 895 shares of the stock were exchanged, compared to its average volume of 4,510. Euronext has a twelve month low of $26.55 and a twelve month high of $44.00. The firm has a 50 day moving average of $37.26 and a 200 day moving average of $34.09.
Euronext Company Profile
Euronext N.V. is a pan-European market infrastructure operator that runs regulated exchanges and trading venues across Europe. Its activities include the listing and trading of equities, exchange-traded funds, bonds, derivatives, warrants and other financial instruments, serving companies, investors, financial institutions and other market participants.
The company also provides market data, indices, issuer services, technology and post-trade infrastructure. Through its clearing and settlement-related operations and other market services, Euronext supports transactions throughout the investment lifecycle.
Euronext was established in 2000 through the combination of the exchanges in Amsterdam, Brussels and Paris.
Recommended Stories
- Five stocks we like better than Euronext
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Euronext Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euronext and related companies with MarketBeat.com's FREE daily email newsletter.
